We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BD DIAGNOSTIC SYSTEMS

BD Diagnostics manufactures and markets medical supplies and devices and diagnostic systems that include cellular ana... read more Featured Products: More products

Download Mobile App




Neutrophil CD64 Index Helps Diagnose Spontaneous Bacterial Peritonitis

By LabMedica International staff writers
Posted on 17 Aug 2016
Spontaneous bacterial peritonitis (SBP) is a common and serious complication in patients with ascites caused by decompensated liver cirrhosis, and most cases are caused by bacterial infections spreading to the peritoneum across the gut wall or mesenteric lymphatics.

Although a diagnostic paracentesis and appropriate ascitic fluid analysis is considered essential for all patients admitted with ascites, the procedure is associated with dangerous complications such as bleeding and infection. In the emergency setting, performing ascitic fluid culture examinations is time-consuming and not always possible.

Scientists affiliated with the Capital Medical Hospital (Beijing, China) conducted a prospective study of a total of 123 patients with ascites caused by cirrhosis who fulfilled the inclusion criteria were enrolled from March 2014 to June 2015. Aspirated ascitic fluid was collected in ethylenediaminetetraacetic acid (EDTA) tubes and analyzed within three hours of aspiration. Relevant tests were performed on blood samples to assess the condition of the patients.

Blood samples were collected within six hours after paracentesis and before antibiotic therapy; they were processed within 24 hours after collection for the measurement of CD64 expression on leukocytes by FACSCalibur flow cytometry (Becton Dickinson, Franklin Lakes, NJ, USA) using a Becton Dickinson CD14/CD64 assay kit. The kit includes fluorescein isothiocyanate (FITC)-conjugated anti-CD14 and phycoerythrin (PE)-conjugated anti-CD64 antibodies. The lymphocyte, monocyte, and neutrophil populations are defined by their forward and side scatter characteristics along with surface CD14 staining.

The teams found that the neutrophil CD64 (Fcγ receptor I) index results were significantly higher in cirrhotic patients with SBP than in those without SBP. There was a positive correlation between the neutrophil CD64 index and the polymorphonuclear neutrophil (PMN) count in ascites. In the receiver operating characteristic curve (ROC) analysis, the area under the curve (AUC) was 0.894. The optimal cut-off value for the neutrophil CD64 index was 2.02. The sensitivity and specificity of the neutrophil CD64 index for cirrhotic patients with SBP were 80.49% and 93.90%, respectively. The elevated neutrophil CD64 index was down regulated by antibiotic therapy.

The authors concluded from the results of their study the neutrophil CD64 index could be used as a sensitive and specific indicator for the diagnosis of SBP in cirrhotic patients with ascites. In addition, the neutrophil CD64 index is modulated by antibiotic therapy and could be used to evaluate the effect of therapy in SBP patients. The study was published on July 4, 2016, in the journal International Journal of Infectious Diseases.

Related Links:
Capital Medical Hospital
Becton Dickinson


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.